All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Bilateral Breast Carcinoma | NCIT_C8287 | [Carcinoma that affects both breasts in a simultaneous or non-simultaneous manner.] |
| Lingula of the Lung | NCIT_C40373 | [A small tongue-like projection from the lower portion of the upper lobe of the left lung.] |
| VFQ25-Interviewer Administered Format - Overall Health | NCIT_C112729 | [Visual Functioning Questionnaire 25-Interviewer Administered Format Version 2000 (VFQ25-Interviewer Administered Format) General Heath and Vision: In general, would you say your overall health is:] |
| Grade 4 Superficial Soft Tissue Fibrosis, CTCAE | NCIT_C146140 | [Generalized; associated with signs or symptoms of impaired breathing or feeding] |
| Superficial Soft Tissue Fibrosis, CTCAE | NCIT_C143866 | [A disorder characterized by fibrotic degeneration of the superficial soft tissues.] |
| Grade 4 Superior Vena Cava Syndrome, CTCAE | NCIT_C146141 | [Life-threatening consequences; urgent multi-modality intervention indicated (e.g., lysis, thrombectomy, surgery)] |
| Superior Vena Cava Syndrome, CTCAE | NCIT_C143868 | [A disorder characterized by obstruction of the blood flow in the superior vena cava. Signs and symptoms include swelling and cyanosis of the face, neck, and upper arms, cough, orthopnea and headache.] |
| Tyrosine-Protein Kinase RYK | NCIT_C29920 | [Tyrosine-protein kinase RYK (604 aa, ~68 kDa) is encoded by the human RYK gene. This protein is involved in receptor signaling, tyrosine phosphorylation and protein-protein interactions.] |
| LIM Domain Kinase 1 | NCIT_C29922 | [LIM domain kinase 1 (647 aa, ~73 kDa) is encoded by the human LIMK1 gene. This protein is involved in both actin cytoskeleton organization and serine/threonine phosphorylation.] |
| LIM and Senescent Cell Antigen-Like-Containing Domain Protein 1 | NCIT_C29923 | [LIM and senescent cell antigen-like-containing domain protein 1 (325 aa, ~37 kDa) is encoded by the human LIMS1 gene. This protein is involved in the propagation of integrin signaling.] |
| Ras-Like Protein Family Member 10A | NCIT_C29913 | [Ras-like protein family member 10A (203 aa, ~23 kDa) is encoded by the human RASL10A gene. This protein plays a role in GTPase activity and the inhibition of cell proliferation.] |
| R7 Virus | NCIT_C29914 | [This virus is a spontaneous mutant of SV7, a molecular clone of MoMuSV124. Like SV7, R7 induces subcutaneous fibrosarcomas, spleen tumors, and mesentery tumors infiltrated by proliferating vessels lined by transformed endothelial cells. However, it also induces brain lesions. (from Virology. 1997 Sep 15;236(1):213-8)] |
| Mouse Leukemia Virus | NCIT_C14244 | [Type C retroviruses that cause leukemia in mice. Includes the Abelson, AKR, Friend, Moloney, Gross, and other leukemia viruses.] |
| Ras Suppressor Protein 1 | NCIT_C29915 | [Ras suppressor protein 1 (277 aa, ~32 kDa) is encoded by the human RSU1 gene. This protein is involved in Ras signaling pathways.] |
| Leucine-Rich Repeat | NCIT_C26197 | [A leucine-rich protein structural motif that forms an alpha/beta horseshoe tertiary structure. It is composed of repeating units of 20-30 amino acid stretches that are rich in leucine residues. This structural motif is found in a wide variety of unrelated proteins.] |
| RSU1 Gene | NCIT_C24757 | [This gene plays a role in signal transduction and is involved in cell adhesion.] |
| Graffi Murine Leukemia Virus | NCIT_C29916 | [A nondefective ecotropic retrovirus that was originally reported to induce myeloid leukemia in some strains of mice; isolated from filtrates of transplantable tumors; a species of gammaretrovirus.] |
| Gross Leukemia Virus | NCIT_C29917 | [A murine reverse-transcribing RNA retrovirus with type C morphology that has been shown to induce lymphatic leukemia in infected mice.] |
| Inactivated Vaccinia Virus | NCIT_C29918 | [A poxvirus made non-infectious by ultraviolet light or other inactivation methods in order to reduce its pathogenicity. In cancer gene therapy, inactivated vaccinia virus may be used as a vector to express a protein that kills tumor cells or elicits specific anti-tumor immunity. In a cancer vaccine application, tumor cells taken from the host may be adsorbed with inactivated vaccinia virus and returned to the host, where the modified tumor cells may stimulate an anti-tumor immune response. (NCI04)] |
| Inactivated Vaccine | NCIT_C29694 | [A preparation of killed microorganisms that is intended to prevent or treat an infectious disease by inducing active immunity to the causative microorganism.] |